---
$id: https://graph.org.ai/products/commodity/51172170
$type: Product
source: UNSPSC
code: "51172170"
title: "Drotaverine hydrochloride"
class: "51172100"
classTitle: "Antispasmodics"
family: "51170000"
familyTitle: "Drugs affecting the gastrointestinal system"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Drotaverine hydrochloride

**UNSPSC Code**: 51172170
**Class**: [Antispasmodics](Antispasmodics.mdx)
**Family**: [Drugs affecting the gastrointestinal system](../Drugs affecting the gastrointestinal system.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antispasmotic agent with the molecular formula C24H31NO4.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 24ZVH4C669, chemically known as 1-benzyl-3,4,6,7-tetraethoxy-1,2,3,4-tetrahydroisoquinoline but more generally known as drotaverine hydrochloride, which bears US NIH Compound Identifier 1712095. European Medicines Agency schedules Drotaverine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01843MIG. Most nations, for tariff and trade purposes, schedule drotaverine hydrochloride under HS 29334990 and SITC 51575. As of Q4 2014, DROTAVERINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Drotaverine hydrochloride bears US NLM NCI C97980. SMILES: CCOC1CCC(CC1OCC)/C=C\2/C3CC(C(CC3CCN2)OCC)OCC.CL.

